Abstract:Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease characterized by misguided thrombolysis and remodeling of pulmonary arteries. MicroRNAs are small non-coding RNAs involved in multiple cell processes and functions. During CTEPH, circulating microRNA profile endued with characteristics of diseased cells could be identified as a biomarker, and might help in recognition of pathogenesis. Thus, in this study, we compared the differentially expressed microRNAs in plasma of CTEPH patients and healthy controls and investigated their potential functions. Microarray was used to identify microRNA expression profile and qRT-PCR for validation. The targets of differentially expressed microRNAs were identified in silico, and the Gene Ontology database and Kyoto Encyclopedia of Genes and Genomes pathway database were used for functional investigation of target gene profile. Targets of let-7b were validated by fluorescence reporter assay. Protein expression of target genes was determined by ELISA or western blotting. Cell migration was evaluated by wound healing assay. The results showed that 1) thirty five microRNAs were differentially expressed in CTEPH patients, among which, a signature of 17 microRNAs, which was shown to be related to the disease pathogenesis by in silico analysis, gave diagnostic efficacy of both sensitivity and specificity >0.9. 2) Let-7b, one of the down-regulated anti-oncogenic microRNAs in the signature, was validated to decrease to about 0.25 fold in CTEPH patients. 3) ET-1 and TGFBR1 were direct targets of let-7b. Altering let-7b level influenced ET-1 and TGFBR1 expression in pulmonary arterial endothelial cells (PAECs) as well as the migration of PAECs and pulmonary arterial smooth muscle cells (PASMCs). These results suggested that CTEPH patients had aberrant microRNA signature which might provide some clue for pathogenesis study and biomarker screening. Reduced let-7b might be involved in the pathogenesis of CTEPH by affecting ET-1 expression and the function of PAECs and PASMCs.

Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem Cells

Advances in Research of Let-7 in Cancer

Let-7c Microrna Expression and Clinical Significance in Hepatocellular Carcinoma.

Let-7 as a Promising Target in Aging and Aging-Related Diseases: A Promise or a Pledge.

MiRNA Let-7B Promotes the Development of Hypoxic Pulmonary Hypertension by Targeting ACE2.

MicroRNA and Its Role in Heart

Protective Effects of Let-7A and Let-7B on Oxidized Low-Density Lipoprotein Induced Endothelial Cell Injuries.

Research advances in the let-7e biological function

MicroRNAs: Novel Regulators of the Heart.

MicroRNA Let-7i negatively regulates cardiac inflammation and fibrosis.

Pivotal Role Of Reduced Let-7g Expression In Breast Cancer Invasion And Metastasis

Cardiomyocyte-derived small extracellular vesicle-transported let-7b-5p modulates cardiac remodeling via TLR7 signaling pathway

Data from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis

Data from the &Lt;i>let-7&Lt;/i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

MicroRNA Let-7C-5p Alleviates in Hepatocellular Carcinoma by Targeting Enhancer of Zeste Homolog 2: A Study Intersecting Bioinformatic Analysis and Validated Experiments

Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis

MicroRNA:important regulator in cardiovascular development and diseases

Differentially Expressed Plasma Micrornas and the Potential Regulatory Function of Let-7b in Chronic Thromboembolic Pulmonary Hypertension.

MicroRNA Let-7C Inhibits Bcl-xl Expression and Regulates Ox-Ldl-induced Endothelial Apoptosis

Advances in neonatal acute respiratory distress syndrome and Let-7 family

Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS.